Home » Prices » NASDAQ:CHRS

Coherus BioSciences, Inc. stock price

Today's NASDAQ:CHRS chart, history & news

Price:
18.62 USD
Change:
+0.57 (3.16%)
Key Stats
Price open 18.11
Previous close 18.05
Market cap 1.34B
Volume 337.54K
Day high 18.62
Day low 18.08
Year high 22.53
Year low 11.67
Year to date change 4.80%
P/E Ratio N.A
Company Profile
Fundamentals
Insider Information
News

About Coherus BioSciences, Inc.

Coherus BioSciences, Inc. is a commercial-stage clinical biologics platform company, which engages in the development and commercialization of biosimilar therapeutics. Its clinical products include pegfilgrastim biosimilar, adalimumab biosimilar, etanercept biosimilar, ranibizumab biosimilar, and aflibercept biosimilar. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Company information

Company name
Coherus Biosciences Inc
Exchange
Sector
Health Technology
Industry
Biotechnology
Employees
291
CEO
Denny M. Lanfear
Address
333 Twin Dolphin Drive, Redwood City, CA, 94065
Country
United States
Contact information
1.650.649.3530
Website
http://www.coherus.com

Related companies

Invezz uses cookies to provide you with a great user experience. By using Invezz, you accept our privacy policy.